Overview

A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Repeat Doses of GSK2586184 and the Effect of Food and Gender

Status:
Completed
Trial end date:
2012-07-31
Target enrollment:
Participant gender:
Summary
A study to investigate the safety, tolerability, pharmacokinetics, and pharmacodynamics of single and repeat doses of 800 mg GSK2586184 in healthy subjects.
Phase:
Phase 1
Details
Lead Sponsor:
GlaxoSmithKline